Early, Late, & Self-Selected Time-Restricted Eating: Impact on Hepatic Fat, Liver Health, & Fecal Microbiota in Adults with Overweight or Obesity
Dote Montero, M.; Clavero-Jimeno, A.; Cortes-Martin, A.; Lopez-Pascual, A.; Merchan-Ramirez, E.; Camacho-Cardenosa, A.; Concepcion, M.; Oses, M.; Lopez-Vazquez, A.; Amaro-Gahete, F. J.; Martin-Olmedo, J. J.; Jurado-Fasoli, L.; De-la-O, A.; Garcia Perez, P. V.; Galvez, J.; Rodriguez-Nogales, A.; Garcia, F.; Mbongo Habimana, C.; Jimenez Vazquez, M.; Alfaro-Magallanes, V. M.; Avila, M. A.; Martin-Rodriguez, J. L.; Cabeza, R.; Munoz-Torres, M.; Labayen, I.; Ruiz, J. R.
Show abstract
Background and aimsThe optimal eating window for time-restricted eating (TRE) remains unclear. We investigated the effects of 8-hour TRE combined with usual care (UC, a Mediterranean diet-based education program), versus UC alone over 12 weeks on hepatic fat fraction, liver health markers, and fecal microbiota in adults with overweight or obesity. MethodsIn this multicenter randomized trial, participants (50% women) were assigned to UC (n=49), early TRE (n=49), late TRE (n=52), or self-selected TRE (n=47). Hepatic fat fraction was assessed by MRI; liver markers included elastography-based parameters, liver enzymes, and circulating biomarkers. Fecal microbiota was analyzed by 16S rRNA gene sequencing. ResultsHepatic fat fraction decreased significantly within the three TRE groups (all P[≤]0.02), but no between-group differences were observed when comparing early TRE (mean difference [MD]: -0.4%; P=0.95), late TRE (MD: -1.5%; P=0.15), and self-selected TRE groups (MD: -0.7%; P=0.77) with the UC group, or among the TRE groups themselves (all P[≥]0.41). Similarly, no between-group differences were found in liver health markers and fecal microbiota. Participants with metabolic dysfunction-associated steatotic liver disease at baseline as well as those achieving [≥]5% weight loss had greater reductions in hepatic fat fraction than those who did not (MD: -2.7 and -2.6%; respectively, both P<0.001). A higher proportion of participants in the TRE groups achieved [≥]5% weight loss compared with UC (41-44% vs 16%; P=0.001). ConclusionThese findings suggest that the timing of the eating window in TRE may not impact liver fat or microbiota composition beyond the effects of weight loss, though the study was not powered for secondary outcomes. The study was registered on ClinicalTrials.gov (identifier: NCT05310721)
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Microbiome-targeting Fiber-enriched Nutritional Formula is Well Tolerated and Improves Quality of Life and Hemoglobin A1c in Type 2 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Trial 94%
- Safety and effects of acetylated and butyrylated high amylose maize starch in recently diagnosed youths with type 1 diabetes; a Pilot Study 94%
- Comparative Effects of Weight Loss and Incretin-Based Therapies on Endothelial Vasodilatory and Fibrinolytic Function 93%
Similar papers in this journal
- The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, Baseline Data, and Early Insights. 94%
- Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study 93%
- MRI assessment of adipose tissue fatty acid composition in the UK Biobank and its association with diet and disease 93%
Similar papers in this journal
- The effects of time-restricted eating vs. standard dietary advice on weight, metabolic health and the consumption of processed food: A pragmatic randomised controlled trial in community-based adults 95%
- Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity 94%
- Tissue-Specific Ablation of Liver Fatty Acid-Binding Protein Induces a Metabolically Healthy Obese Phenotype in Female Mice 93%
Similar papers in this journal
- Weight Loss-Independent Changes in Human Growth Hormone During Water-Only Fasting: A Secondary Evaluation of a Randomized Controlled Trial 93%
- Patterns and Predictors of Weight Loss with Exenatide Treatment in Overweight and Obese Women 93%
- Metformin strongly affects gut microbiome composition in high-fat diet-induced type 2 diabetes mouse model of both sexes 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.